Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Mehr anzeigen
CAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced positive results...
CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the appointment of...
CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce...
CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0904 | 17.7428851816 | 0.5095 | 0.64 | 0.3801 | 6787854 | 0.43900169 | CS |
| 4 | 0.3509 | 140.923694779 | 0.249 | 0.96 | 0.240601 | 38225931 | 0.45500475 | CS |
| 12 | -0.5001 | -45.4636363636 | 1.1 | 1.25 | 0.2212 | 11898654 | 0.44785384 | CS |
| 26 | -1.5501 | -72.0976744186 | 2.15 | 2.29 | 0.2212 | 5209051 | 0.45012473 | CS |
| 52 | -0.7601 | -55.8897058824 | 1.36 | 2.625 | 0.2212 | 2619017 | 0.45253931 | CS |
| 156 | -3.6001 | -85.7166666667 | 4.2 | 7.15 | 0.2212 | 1184453 | 0.52436201 | CS |
| 260 | -3.6001 | -85.7166666667 | 4.2 | 7.15 | 0.2212 | 1184453 | 0.52436201 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
